{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:10:04Z","timestamp":1791655804562,"version":"4.3.4"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"-Project of the Latvian Science Fund \u201cHuman papillomavirus genome associated correlates of disease progression and treatment response for cervical neoplasms and cancer\u201d","award":["LZP-2021\/1-0484"],"award-info":[{"award-number":["LZP-2021\/1-0484"]}]},{"name":"-Project of the Latvian Science Fund \u201cHuman papillomavirus genome associated correlates of disease progression and treatment response for cervical neoplasms and cancer\u201d","award":["LZP-2021\/1-0484"],"award-info":[{"award-number":["LZP-2021\/1-0484"]}]},{"name":"-Project of the Latvian Science Fund \u201cHuman papillomavirus genome associated correlates of disease progression and treatment response for cervical neoplasms and cancer\u201d","award":["LZP-2021\/1-0484"],"award-info":[{"award-number":["LZP-2021\/1-0484"]}]},{"name":"-Project of the Latvian Science Fund \u201cHuman papillomavirus genome associated correlates of disease progression and treatment response for cervical neoplasms and cancer\u201d","award":["LZP-2021\/1-0484"],"award-info":[{"award-number":["LZP-2021\/1-0484"]}]},{"name":"-Project of the Latvian Science Fund \u201cHuman papillomavirus genome associated correlates of disease progression and treatment response for cervical neoplasms and cancer\u201d","award":["LZP-2021\/1-0484"],"award-info":[{"award-number":["LZP-2021\/1-0484"]}]},{"name":"-Project of the Latvian Science Fund \u201cHuman papillomavirus genome associated correlates of disease progression and treatment response for cervical neoplasms and cancer\u201d","award":["LZP-2021\/1-0484"],"award-info":[{"award-number":["LZP-2021\/1-0484"]}]},{"DOI":"10.13039\/501100014434","name":"Narodowa Agencja Wymiany Akademickiej","doi-asserted-by":"publisher","award":["PPI\/APM\/2018\/1\/00007\/U001"],"award-info":[{"award-number":["PPI\/APM\/2018\/1\/00007\/U001"]}],"id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014434","name":"Narodowa Agencja Wymiany Akademickiej","doi-asserted-by":"publisher","award":["PPI\/APM\/2018\/1\/00007\/U001"],"award-info":[{"award-number":["PPI\/APM\/2018\/1\/00007\/U001"]}],"id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014434","name":"Narodowa Agencja Wymiany Akademickiej","doi-asserted-by":"publisher","award":["PPI\/APM\/2018\/1\/00007\/U001"],"award-info":[{"award-number":["PPI\/APM\/2018\/1\/00007\/U001"]}],"id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ERASMUS Internship","award":["\"Erasmus+ Programm \u00fcber die Universit\u00e4t Hamburg\""],"award-info":[{"award-number":["\"Erasmus+ Programm \u00fcber die Universit\u00e4t Hamburg\""]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NIHR01CA217715"],"award-info":[{"award-number":["NIHR01CA217715"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NIHR01CA217715"],"award-info":[{"award-number":["NIHR01CA217715"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"DOI":"10.1186\/s13027-025-00682-y","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T10:18:45Z","timestamp":1753525125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["New mouse model based on adenocarcinoma 4T1 cells expressing HPV16 E6 and E7 applied to assess the efficacy of therapeutic and prophylactic E6\/E7-based HPV16 vaccines"],"prefix":"10.1186","volume":"20","author":[{"given":"Juris","family":"Jansons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Avdoshina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alesja","family":"Dudorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Royo","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liba","family":"Sokolovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Perminov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilze","family":"Lindenberga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Gebrila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sona","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dace","family":"Skrastina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurijs","family":"Nazarovs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Palefsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Isaguliants","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"682_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.20892\/j.issn.2095-3941.2020.0370","volume":"17","author":"K Anna Szymonowicz","year":"2020","unstructured":"Anna Szymonowicz K, Chen J. Biological and clinical aspects of HPV-related cancers. Cancer Biol Med. 2020;17:864\u201378.","journal-title":"Cancer Biol Med"},{"key":"682_CR2","doi-asserted-by":"publisher","unstructured":"Arbyn M, Xu L, Simoens C, Martin-Hirsch PP. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group, editor. Cochrane Database Syst Rev. 2018 [cited 2025 Mar 1];2020. Available from: https:\/\/doi.org\/10.1002\/14651858.CD009069.pub3","DOI":"10.1002\/14651858.CD009069.pub3"},{"key":"682_CR3","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1134\/S0006297919070101","volume":"84","author":"MS Vonsky","year":"2019","unstructured":"Vonsky MS, Runov AL, Gordeychuk IV, Isaguliants MG. Therapeutic vaccines against human papilloma viruses: achievements and prospects. Biochem Mosc. 2019;84:800\u201316.","journal-title":"Biochem Mosc"},{"key":"682_CR4","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1080\/15384047.2017.1310349","volume":"19","author":"M Di Domenico","year":"2018","unstructured":"Di Domenico M, Giovane G, Kouidhi S, Iorio R, Romano M, De Francesco F, et al. HPV epigenetic mechanisms related to oropharyngeal and cervix cancers. Cancer Biol Ther. 2018;19:850\u20137.","journal-title":"Cancer Biol Ther"},{"key":"682_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2147\/ITT.S273327","volume":"9","author":"C Smalley Rumfield","year":"2020","unstructured":"Smalley Rumfield C, Roller N, Pellom ST, Schlom J, Jochems C. Therapeutic vaccines for HPV-Associated malignancies. ImmunoTargets Ther. 2020;9:167\u2013200.","journal-title":"ImmunoTargets Ther"},{"key":"682_CR6","doi-asserted-by":"publisher","first-page":"1362770","DOI":"10.3389\/fimmu.2024.1362770","volume":"15","author":"R Wang","year":"2024","unstructured":"Wang R, Huang H, Yu C, Li X, Wang Y, Xie L. Current status and future directions for the development of human papillomavirus vaccines. Front Immunol. 2024;15:1362770.","journal-title":"Front Immunol"},{"key":"682_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/vaccines12040428","volume":"12","author":"S Alouini","year":"2024","unstructured":"Alouini S, Pichon C. Therapeutic vaccines for HPV-Associated cervical malignancies: A systematic review. Vaccines. 2024;12:428.","journal-title":"Vaccines"},{"key":"682_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1080\/14760584.2024.2374287","volume":"23","author":"A Demidova","year":"2024","unstructured":"Demidova A, Douguet L, Fert I, Wei Y, Charneau P, Majlessi L. Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers. Expert Rev Vaccines. 2024;23:674\u201387.","journal-title":"Expert Rev Vaccines"},{"key":"682_CR9","doi-asserted-by":"crossref","unstructured":"Esquerr\u00e9 M, Bouillette-Marussig M, Goubier A, Momot M, Gonindard C, Keller H et al. GTL001, a bivalent therapeutic vaccine against human papillomavirus 16 and 18, induces antigen-specific CD8\u2009+\u2009T cell responses leading to tumor regression. Meyers C, editor. PLOS ONE. 2017;12:e0174038.","DOI":"10.1371\/journal.pone.0174038"},{"key":"682_CR10","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/cancers16030672","volume":"16","author":"CA Gon\u00e7alves","year":"2024","unstructured":"Gon\u00e7alves CA, Pereira-da-Silva G, Silveira RCCP, Mayer PCM, Zilly A, Lopes-J\u00fanior LC, Safety. Efficacy, and immunogenicity of therapeutic vaccines for patients with High-Grade cervical intraepithelial neoplasia (CIN 2\/3) associated with human papillomavirus: A systematic review. Cancers. 2024;16:672.","journal-title":"Cancers"},{"key":"682_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ddmod.2020.10.002","volume":"32","author":"S Dorfer","year":"2020","unstructured":"Dorfer S, Handisurya A. Model systems for papillomavirus-associated skin disease. Drug Discov Today Dis Models. 2020;32:7\u201316.","journal-title":"Drug Discov Today Dis Models"},{"key":"682_CR12","doi-asserted-by":"crossref","unstructured":"Spurgeon ME, Lambert PF. Mus musculus Papillomavirus 1: a New Frontier in Animal Models of Papillomavirus Pathogenesis. Tarakanova VL, editor. J Virol. 2020;94:e00002-20.","DOI":"10.1128\/JVI.00002-20"},{"key":"682_CR13","doi-asserted-by":"publisher","first-page":"001540","DOI":"10.1099\/jgv.0.001540","volume":"102","author":"JA Scarth","year":"2021","unstructured":"Scarth JA, Patterson MR, Morgan EL, Macdonald A. The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation. J Gen Virol. 2021;102:001540.","journal-title":"J Gen Virol"},{"key":"682_CR14","doi-asserted-by":"publisher","first-page":"5020","DOI":"10.3390\/ijms21145020","volume":"21","author":"S Peixoto Da Silva","year":"2020","unstructured":"Peixoto Da Silva S, Santos JMO, Mestre VF, Medeiros-Fonseca B, Oliveira PA, Bastos MSM. Human papillomavirus 16-Transgenic mice as a model to study Cancer-Associated Cachexia. Int J Mol Sci. 2020;21:5020.","journal-title":"Int J Mol Sci"},{"key":"682_CR15","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1101\/gad.6.8.1444","volume":"6","author":"J Cheng","year":"1992","unstructured":"Cheng J, Turksen K, Yu QC, Schreiber H, Teng M, Fuchs E. Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha Transgenic mice. Genes Dev. 1992;6:1444\u201356.","journal-title":"Genes Dev"},{"key":"682_CR16","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/j.1460-2075.1993.tb05738.x","volume":"12","author":"L Guo","year":"1993","unstructured":"Guo L, Yu QC, Fuchs E. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in Transgenic mice. EMBO J. 1993;12:973\u201386.","journal-title":"EMBO J"},{"key":"682_CR17","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1002\/lary.26679","volume":"127","author":"ND Facompre","year":"2017","unstructured":"Facompre ND, Sahu V, Montone KT, Harmeyer KM, Nakagawa H, Rustgi AK, et al. Barriers to generating PDX models of HPV-related head and neck cancer. Laryngoscope. 2017;127:2777\u201383.","journal-title":"Laryngoscope"},{"key":"682_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1158\/2326-6066.CIR-16-0358","volume":"6","author":"Y-H Lin","year":"2018","unstructured":"Lin Y-H, Yang M-C, Tseng S-H, Jiang R, Yang A, Farmer E, et al. Integration of oncogenes via sleeping beauty as a mouse model of HPV16\u2009+\u2009Oral tumors and Immunologic control. Cancer Immunol Res. 2018;6:305\u201319.","journal-title":"Cancer Immunol Res"},{"key":"682_CR19","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1158\/0008-5472.CAN-21-0399","volume":"81","author":"TR Henkle","year":"2021","unstructured":"Henkle TR, Lam B, Kung YJ, Lin J, Tseng S-H, Ferrall L, et al. Development of a novel mouse model of spontaneous High-Risk HPVE6\/E7\u2013Expressing carcinoma in the cervicovaginal tract. Cancer Res. 2021;81:4560\u20139.","journal-title":"Cancer Res"},{"key":"682_CR20","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00262-015-1734-0","volume":"64","author":"A Venuti","year":"2015","unstructured":"Venuti A, Curzio G, Mariani L, Paolini F. Immunotherapy of HPV-associated cancer: DNA\/plant-derived vaccines and new orthotopic mouse models. Cancer Immunol Immunother. 2015;64:1329\u201338.","journal-title":"Cancer Immunol Immunother"},{"key":"682_CR21","doi-asserted-by":"publisher","first-page":"534","DOI":"10.4161\/hv.23232","volume":"9","author":"F Paolini","year":"2013","unstructured":"Paolini F, Massa S, Manni I, Franconi R, Venuti A. Immunotherapy in new pre-clinical models of HPV-associated oral cancers. Hum Vaccines Immunother. 2013;9:534\u201343.","journal-title":"Hum Vaccines Immunother"},{"key":"682_CR22","doi-asserted-by":"publisher","first-page":"e0149748","DOI":"10.1371\/journal.pone.0149748","volume":"11","author":"L-L Li","year":"2016","unstructured":"Li L-L, Wang H-R, Zhou Z-Y, Luo J, Wang X-L, Xiao X-Q et al. M McLaughlin-Drubin editor 2016 C3-Luc cells are an excellent model for evaluation of cellular immunity following HPV16L1 vaccination. PLoS ONE 11 e0149748.","journal-title":"PLoS ONE"},{"key":"682_CR23","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.3389\/fimmu.2020.01750","volume":"11","author":"S Zottnick","year":"2020","unstructured":"Zottnick S, Vo\u00df AL, Riemer AB. Inducing immunity where it matters: orthotopic HPV tumor models and therapeutic vaccinations. Front Immunol. 2020;11:1750.","journal-title":"Front Immunol"},{"key":"682_CR24","doi-asserted-by":"publisher","first-page":"24194","DOI":"10.18632\/oncotarget.8254","volume":"7","author":"DW Vermeer","year":"2016","unstructured":"Vermeer DW, Coppock JD, Zeng E, Lee KM, Spanos WC, Onken MD, et al. Metastatic model of HPV\u2009+\u2009oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis. Oncotarget. 2016;7:24194\u2013207.","journal-title":"Oncotarget"},{"key":"682_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1084\/jem.170.1.87","volume":"170","author":"D Lo","year":"1989","unstructured":"Lo D, Burkly LC, Flavell RA, Palmiter RD, Brinster RL. Tolerance in Transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells. J Exp Med. 1989;170:87\u2013104.","journal-title":"J Exp Med"},{"key":"682_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/jpm10030064","volume":"10","author":"T Goto","year":"2020","unstructured":"Goto T. Patient-Derived tumor xenograft models: toward the establishment of precision Cancer medicine. J Pers Med. 2020;10:64.","journal-title":"J Pers Med"},{"key":"682_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1134\/S0026893322050028","volume":"56","author":"DV Avdoshina","year":"2022","unstructured":"Avdoshina DV, Kondrashova AS, Belikova MG, Bayurova EO. Murine models of chronic viral infections and associated cancers. Mol Biol. 2022;56:649\u201367.","journal-title":"Mol Biol"},{"key":"682_CR28","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.3390\/cancers16203474","volume":"16","author":"Z Lu","year":"2024","unstructured":"Lu Z, Haghollahi S, Afzal M. Potential therapeutic targets for the treatment of HPV-Associated malignancies. Cancers. 2024;16:3474.","journal-title":"Cancers"},{"key":"682_CR29","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3892\/ol.2015.2911","volume":"9","author":"Y-L Li","year":"2015","unstructured":"Li Y-L, Ma Z-L, Zhao Y, Zhang J. Immunization with mutant HPV16 E7 protein inhibits the growth of TC-1 cells in tumor-bearing mice. Oncol Lett. 2015;9:1851\u20136.","journal-title":"Oncol Lett"},{"key":"682_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.imlet.2006.07.003","volume":"107","author":"R Samorski","year":"2006","unstructured":"Samorski R, Gissmann L, Osen W. Codon optimized expression of HPV 16 E6 renders target cells susceptible to E6-specific CTL recognition. Immunol Lett. 2006;107:41\u20139.","journal-title":"Immunol Lett"},{"key":"682_CR31","doi-asserted-by":"publisher","first-page":"34070","DOI":"10.18632\/oncotarget.15977","volume":"8","author":"A Cerasuolo","year":"2017","unstructured":"Cerasuolo A, Annunziata C, Tortora M, Starita N, Stellato G, Greggi S, et al. Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma. Oncotarget. 2017;8:34070\u201381.","journal-title":"Oncotarget"},{"key":"682_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12885-017-3124-9","volume":"17","author":"D Hong","year":"2017","unstructured":"Hong D, Liu J, Hu Y, Lu X, Li B, Li Y, et al. Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16. BMC Cancer. 2017;17:136.","journal-title":"BMC Cancer"},{"key":"682_CR33","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1177\/0963689718788521","volume":"27","author":"M-Z Wu","year":"2018","unstructured":"Wu M-Z, Li W-N, Cha N, Tian L-X, Zhang Y, Wu X, et al. Diagnostic utility of HPV16 E6 mRNA or E7 mRNA quantitative expression for cervical cells of patients with dysplasia and carcinoma. Cell Transpl. 2018;27:1401\u20136.","journal-title":"Cell Transpl"},{"key":"682_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jcv.2018.08.008","volume":"108","author":"Z Wu","year":"2018","unstructured":"Wu Z, Yu L, Lei X, Qin Y, Zhang X, Chen W, et al. The association between human papillomavirus 16, 18 DNA load and E6 protein expression in cervical intraepithelial neoplasia and cancer. J Clin Virol. 2018;108:6\u201311.","journal-title":"J Clin Virol"},{"key":"682_CR35","doi-asserted-by":"publisher","first-page":"e29875","DOI":"10.1002\/jmv.29875","volume":"96","author":"E Jacquin","year":"2024","unstructured":"Jacquin E, Saunier M, Lepiller Q, Monnien F, Mauny F, Ramanah R, et al. The level of expression of HPV16 early transcripts is not associated with the natural history of cervical lesions. J Med Virol. 2024;96:e29875.","journal-title":"J Med Virol"},{"key":"682_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41416-023-02490-w","volume":"130","author":"L Downham","year":"2024","unstructured":"Downham L, Jaafar I, Rol ML, Nyawira Nyaga V, Valls J, Baena A, et al. Accuracy of HPV E6\/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis. Br J Cancer. 2024;130:517\u201325.","journal-title":"Br J Cancer"},{"key":"682_CR37","first-page":"731","volume":"27","author":"M Smahel","year":"2005","unstructured":"Smahel M, Smahelov\u00e1 J, Tejklov\u00e1 P, Tachezy R, Marinov I. Characterization of cell lines derived from tumors induced by TC-1 cells in mice preimmunized against HPV16 E7 oncoprotein. Int J Oncol. 2005;27:731\u201342.","journal-title":"Int J Oncol"},{"key":"682_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/(SICI)1097-0215(19980925)78:1<41::AID-IJC8>3.0.CO;2-X","volume":"78","author":"H Ji","year":"1998","unstructured":"Ji H, Chang EY, Lin K-Y, Kurman RJ, Pardoll DM, Wu T-C. Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein. Int J Cancer. 1998;78:41\u20135.","journal-title":"Int J Cancer"},{"key":"682_CR39","first-page":"176","volume":"15","author":"M Sadraeian","year":"2013","unstructured":"Sadraeian M, Khoshnood Mansoorkhani MJ, Mohkam M, Rasoul-Amini S, Hesaraki M, Ghasemi Y. Prevention and Inhibition of TC-1 cell growth in tumor bearing mice by HPV16 E7 protein in fusion with Shiga toxin B-Subunit from shigella dysenteriae. Cell J Yakhteh. 2013;15:176\u201381.","journal-title":"Cell J Yakhteh"},{"key":"682_CR40","first-page":"8062","volume":"10","author":"O Saucedo-C\u00e1rdenas","year":"2017","unstructured":"Saucedo-C\u00e1rdenas O, Garc\u00eda-Garza R, Ram\u00edrez-Dur\u00f3n R, Mu\u00f1oz-Maldonado GE, Villanueva-Olivo A, Montes-de-Oca-Luna R, et al. Invasion of TC-1 cells to skeletal muscle fibers protect them from peroxisomicine A1 (T-514) treatment in a murine model of cancer. Int J Clin Exp Pathol. 2017;10:8062\u201371.","journal-title":"Int J Clin Exp Pathol"},{"key":"682_CR41","doi-asserted-by":"publisher","first-page":"105638","DOI":"10.1016\/j.jcv.2023.105638","volume":"170","author":"A O\u0161trbenk Valen\u010dak","year":"2024","unstructured":"O\u0161trbenk Valen\u010dak A, Cuschieri K, Connor L, Zore A, Smrkolj \u0160, Poljak M. Allplex HPV HR detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening. J Clin Virol. 2024;170:105638.","journal-title":"J Clin Virol"},{"key":"682_CR42","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1111\/jcmm.13216","volume":"21","author":"X Wang","year":"2017","unstructured":"Wang X, Xu Z, Tian Z, Zhang X, Xu D, Li Q, et al. The EF-1\u03b1 promoter maintains high\u2010level transgene expression from episomal vectors in transfected CHO\u2010K1 cells. J Cell Mol Med. 2017;21:3044\u201354.","journal-title":"J Cell Mol Med"},{"key":"682_CR43","doi-asserted-by":"publisher","first-page":"29831","DOI":"10.1016\/S0021-9258(18)43956-7","volume":"269","author":"N Wakabayashi-Ito","year":"1994","unstructured":"Wakabayashi-Ito N, Nagata S. Characterization of the regulatory elements in the promoter of the human elongation factor-1 alpha gene. J Biol Chem. 1994;269:29831\u20137.","journal-title":"J Biol Chem"},{"key":"682_CR44","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1089\/vim.2006.19.468","volume":"19","author":"O Peralta-Zaragoza","year":"2006","unstructured":"Peralta-Zaragoza O, Berm\u00fadez-Morales V, Guti\u00e9rrez-Xicotencatl L, Alcocer-Gonz\u00e1lez J, Recillas-Targa F, Madrid-Marina V. E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor \u03b21 promoter throughout Sp1 recognition sequence. Viral Immunol. 2006;19:468\u201380.","journal-title":"Viral Immunol"},{"key":"682_CR45","first-page":"21","volume":"56","author":"KY Lin","year":"1996","unstructured":"Lin KY, Guarnieri FG, Staveley-O\u2019Carroll KF, Levitsky HI, August JT, Pardoll DM, et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 1996;56:21\u20136.","journal-title":"Cancer Res"},{"key":"682_CR46","doi-asserted-by":"crossref","unstructured":"Lorenz TC. Polymerase chain reaction: basic protocol plus troubleshooting and optimization strategies. J Vis Exp. 2012;3998.","DOI":"10.3791\/3998-v"},{"key":"682_CR47","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/vaccines8020318","volume":"8","author":"J Jansons","year":"2020","unstructured":"Jansons J, Bayurova E, Skrastina D, Kurlanda A, Fridrihsone I, Kostyushev D, et al. Expression of the reverse transcriptase domain of telomerase reverse transcriptase induces lytic cellular response in DNA-Immunized mice and limits tumorigenic and metastatic potential of murine adenocarcinoma 4T1 cells. Vaccines. 2020;8:318.","journal-title":"Vaccines"},{"key":"682_CR48","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3389\/fonc.2020.01195","volume":"10","author":"B Schr\u00f6rs","year":"2020","unstructured":"Schr\u00f6rs B, Boegel S, Albrecht C, Bukur T, Bukur V, Holtstr\u00e4ter C, et al. Multi-Omics characterization of the 4T1 murine mammary gland tumor model. Front Oncol. 2020;10:1195.","journal-title":"Front Oncol"},{"key":"682_CR49","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/1566523214666141127095336","volume":"15","author":"O Negre","year":"2015","unstructured":"Negre O, Bartholomae C, Beuzard Y, Cavazzana M, Christiansen L, Courne C, et al. Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of \u03b2-Thalassemia and sickle cell disease. Curr Gene Ther. 2015;15:64\u201381.","journal-title":"Curr Gene Ther"},{"key":"682_CR50","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1158\/1078-0432.CCR-16-2203","volume":"23","author":"TM Brand","year":"2017","unstructured":"Brand TM, Hartmann S, Bhola NE, Peyser ND, Li H, Zeng Y, et al. Human papillomavirus regulates HER3 expression in head and neck cancer: implications for targeted HER3 therapy in HPV\u2009+\u2009Patients. Clin Cancer Res Off J Am Assoc Cancer Res. 2017;23:3072\u201383.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"682_CR51","doi-asserted-by":"publisher","unstructured":"Assessment of Inflammation in Animal Models. (Quantification of TNFA, IFNG, IL4, and IL10 mRNAs by Real-Time PCR)| Springer Nature Experiments. [cited 2025 Mar 27]. Available from: https:\/\/experiments.springernature.com\/articles\/https:\/\/doi.org\/10.1007\/978-1-0716-2509-5_36","DOI":"10.1007\/978-1-0716-2509-5_36"},{"key":"682_CR52","first-page":"71","volume":"3","author":"X Rao","year":"2013","unstructured":"Rao X, Huang X, Zhou Z, Lin X. An improvement of the 2\u02c6(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath. 2013;3:71\u201385.","journal-title":"Biostat Bioinforma Biomath"},{"key":"682_CR53","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3390\/microorganisms9051073","volume":"9","author":"J Jansons","year":"2021","unstructured":"Jansons J, Skrastina D, Kurlanda A, Petkov S, Avdoshina D, Kuzmenko Y, et al. Reciprocal Inhibition of Immunogenic performance in mice of two potent DNA immunogens targeting HCV-Related liver Cancer. Microorganisms. 2021;9:1073.","journal-title":"Microorganisms"},{"key":"682_CR54","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3390\/microorganisms9061219","volume":"9","author":"M Isaguliants","year":"2021","unstructured":"Isaguliants M, Krotova O, Petkov S, Jansons J, Bayurova E, Mezale D, et al. Cellular immune response induced by DNA immunization of mice with drug resistant integrases of HIV-1 clade A offers partial protection against growth and metastatic activity of Integrase-Expressing adenocarcinoma cells. Microorganisms. 2021;9:1219.","journal-title":"Microorganisms"},{"key":"682_CR55","doi-asserted-by":"publisher","first-page":"891","DOI":"10.7863\/jum.2010.29.6.891","volume":"29","author":"GD Ayers","year":"2010","unstructured":"Ayers GD, McKinley ET, Zhao P, Fritz JM, Metry RE, Deal BC, et al. Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurements. J Ultrasound Med. 2010;29:891\u2013901.","journal-title":"J Ultrasound Med"},{"key":"682_CR56","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/bio.2012.0052","volume":"11","author":"TJ Kokkat","year":"2013","unstructured":"Kokkat TJ, Patel MS, McGarvey D, LiVolsi VA, Baloch ZW. Archived Formalin-Fixed Paraffin-Embedded (FFPE) blocks: A valuable underexploited resource for extraction of DNA, RNA, and protein. Biopreservation Biobanking. 2013;11:101\u20136.","journal-title":"Biopreservation Biobanking"},{"key":"682_CR57","unstructured":"Protocols for IHC.| Abcam. [cited 2025 Mar 27]. Available from: https:\/\/www.abcam.com\/en-us\/technical-resources\/applications\/immunohistochemistry\/protocols"},{"key":"682_CR58","doi-asserted-by":"crossref","unstructured":"Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and Eosin staining of tissue and cell sections. Cold Spring Harb Protoc. 2008;2008:pdb.prot4986.","DOI":"10.1101\/pdb.prot4986"},{"key":"682_CR59","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/CJI.0000000000000156","volume":"40","author":"J Chandra","year":"2017","unstructured":"Chandra J, Dutton JL, Li B, Woo W-P, Xu Y, Tolley LK, et al. DNA vaccine encoding HPV16 oncogenes E6 and E7 induces potent Cell-mediated and humoral immunity which protects in tumor challenge and drives E7-expressing skin graft rejection. J Immunother. 2017;40:62\u201370.","journal-title":"J Immunother"},{"key":"682_CR60","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/cancers15010238","volume":"15","author":"S Petkov","year":"2022","unstructured":"Petkov S, Kilpel\u00e4inen A, Bayurova E, Latanova A, Mezale D, Fridrihsone I, et al. HIV-1 protease as DNA immunogen against drug resistance in HIV-1 infection: DNA immunization with drug resistant HIV-1 protease protects mice from challenge with protease-Expressing cells. Cancers. 2022;15:238.","journal-title":"Cancers"},{"key":"682_CR61","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/bcr1530","volume":"8","author":"A Fantozzi","year":"2006","unstructured":"Fantozzi A, Christofori G. Mouse models of breast cancer metastasis. Breast Cancer Res. 2006;8:212.","journal-title":"Breast Cancer Res"},{"key":"682_CR62","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.surg.2013.02.002","volume":"153","author":"OM Rashid","year":"2013","unstructured":"Rashid OM, Nagahashi M, Ramachandran S, Graham L, Yamada A, Spiegel S, et al. Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden. Surgery. 2013;153:771\u20138.","journal-title":"Surgery"},{"key":"682_CR63","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.1038\/s41598-017-07851-z","volume":"7","author":"VP Baklaushev","year":"2017","unstructured":"Baklaushev VP, Kilpel\u00e4inen A, Petkov S, Abakumov MA, Grinenko NF, Yusubalieva GM, et al. Luciferase expression allows bioluminescence imaging but imposes limitations on the orthotopic mouse (4T1) model of breast Cancer. Sci Rep. 2017;7:7715.","journal-title":"Sci Rep"},{"key":"682_CR64","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.biochi.2024.08.009","volume":"228","author":"M Isaguliants","year":"2025","unstructured":"Isaguliants M, Zhitkevich A, Petkov S, Gorodnicheva T, Mezale D, Fridrihsone I, et al. Enzymatic activity of HIV-1 protease defines migration of tumor cells in vitro and enhances their metastatic activity in vivo. Biochimie. 2025;228:32\u201343.","journal-title":"Biochimie"},{"key":"682_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6016278","volume":"2019","author":"E Bayurova","year":"2019","unstructured":"Bayurova E, Jansons J, Skrastina D, Smirnova O, Mezale D, Kostyusheva A, et al. HIV-1 reverse transcriptase promotes tumor growth and metastasis formation via ROS-Dependent upregulation of twist. Oxid Med Cell Longev. 2019;2019:1\u201328.","journal-title":"Oxid Med Cell Longev"},{"key":"682_CR66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.virol.2013.05.012","volume":"445","author":"K Van Doorslaer","year":"2013","unstructured":"Van Doorslaer K. Evolution of the papillomaviridae. Virology. 2013;445:11\u201320.","journal-title":"Virology"},{"key":"682_CR67","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1134\/S0026893324700213","volume":"58","author":"EE Zelenova","year":"2024","unstructured":"Zelenova EE, Karlsen AA, Avdoshina DV, Kyuregyan KK, Belikova MG, Trotsenko ID. Amino acid substitution patterns in the E6 and E7 proteins of HPV type 16: phylogeography and evolution. Mol Biol. 2024;58:611\u201335.","journal-title":"Mol Biol"},{"key":"682_CR68","doi-asserted-by":"crossref","unstructured":"Kukimoto I, Maehama T, Sekizuka T, Ogasawara Y, Kondo K, Kusumoto-Matsuo R et al. Genetic Variation of Human Papillomavirus Type 16 in Individual Clinical Specimens Revealed by Deep Sequencing. Burk RD, editor. PLoS ONE. 2013;8:e80583.","DOI":"10.1371\/journal.pone.0080583"},{"key":"682_CR69","doi-asserted-by":"publisher","first-page":"26476","DOI":"10.1038\/s41598-024-77126-x","volume":"14","author":"JLN Souza","year":"2024","unstructured":"Souza JLN, Antunes-Porto AR, Da Silva Oliveira I, Amorim CCO, Pires LO, De Brito Duval I, et al. Screening and validating the optimal panel of housekeeping genes for 4T1 breast carcinoma and metastasis studies in mice. Sci Rep. 2024;14:26476.","journal-title":"Sci Rep"},{"key":"682_CR70","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s11248-022-00319-5","volume":"31","author":"N Battulin","year":"2022","unstructured":"Battulin N, Korablev A, Ryzhkova A, Smirnov A, Kabirova E, Khabarova A, et al. The human EF1a promoter does not provide expression of the transgene in mice. Transgenic Res. 2022;31:525\u201335.","journal-title":"Transgenic Res"},{"key":"682_CR71","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mrrev.2016.09.006","volume":"772","author":"J Durzynska","year":"2017","unstructured":"Durzynska J, Lesniewicz K, Poreba E. Human papillomaviruses in epigenetic regulations. Mutat Res Mutat Res. 2017;772:36\u201350.","journal-title":"Mutat Res Mutat Res"},{"key":"682_CR72","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.3390\/biomedicines12112571","volume":"12","author":"K Sounbuli","year":"2024","unstructured":"Sounbuli K, Alekseeva LA, Sen\u2019kova AV, Savin IA, Zenkova MA, Mironova NL. Tbp and Hprt1 are appropriate reference genes for Splenic neutrophils isolated from healthy or Tumor-Bearing mice. Biomedicines. 2024;12:2571.","journal-title":"Biomedicines"},{"key":"682_CR73","doi-asserted-by":"publisher","first-page":"262","DOI":"10.17305\/bb.2023.9775","volume":"24","author":"Y Lu","year":"2024","unstructured":"Lu Y, Chen R, Zhang H, Sun X, Li X, Yang M, et al. Prognostic significance and immunological role of HPRT1 in human cancers. Biomol Biomed. 2024;24:262\u201391.","journal-title":"Biomol Biomed"},{"key":"682_CR74","doi-asserted-by":"publisher","first-page":"e20174","DOI":"10.1016\/j.heliyon.2023.e20174","volume":"9","author":"L Yuan","year":"2023","unstructured":"Yuan L, Xiao Z, Lu R. Hypoxanthine guanine phosphoribosyltransferase 1, a target of miR-125b-5p, promotes cell proliferation and invasion in head and neck squamous cell carcinoma. Heliyon. 2023;9:e20174.","journal-title":"Heliyon"},{"key":"682_CR75","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/sj.onc.1201202","volume":"15","author":"D Pim","year":"1997","unstructured":"Pim D, Massimi P, Banks L. Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth. Oncogene. 1997;15:257\u201364.","journal-title":"Oncogene"},{"key":"682_CR76","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/jcm7120530","volume":"7","author":"C Camus","year":"2018","unstructured":"Camus C, Vitale S, Loubatier C, P\u00e9naranda G, Khiri H, Plauzolles A, et al. Quantification of HPV16 E6\/E7 mRNA spliced isoforms viral load as a novel diagnostic tool for improving cervical Cancer screening. J Clin Med. 2018;7:530.","journal-title":"J Clin Med"},{"key":"682_CR77","doi-asserted-by":"crossref","unstructured":"Ajiro M, Zheng Z-M. E6^E7, a Novel Splice Isoform Protein of Human Papillomavirus 16, Stabilizes Viral E6 and E7 Oncoproteins via HSP90 and GRP78. Imperiale MJ, editor. mBio. 2015;6:e02068-14.","DOI":"10.1128\/mBio.02068-14"},{"key":"682_CR78","doi-asserted-by":"publisher","first-page":"1443868","DOI":"10.3389\/fcimb.2024.1443868","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen F, Qu W, Gong Y, Wang Y, Chen L, et al. Alternative splicing in the genome of HPV and its regulation. Front Cell Infect Microbiol. 2024;14:1443868.","journal-title":"Front Cell Infect Microbiol"},{"key":"682_CR79","doi-asserted-by":"crossref","unstructured":"Kim J-B, Urban K, Cochran E, Lee S, Ang A, Rice B et al. Non-Invasive Detection of a Small Number of Bioluminescent Cancer Cells In Vivo. Swarbrick A, editor. PLoS ONE. 2010;5:e9364.","DOI":"10.1371\/journal.pone.0009364"},{"key":"682_CR80","doi-asserted-by":"crossref","unstructured":"Dai C, Sun F, Zhu C, Hu X. Tumor Environmental Factors Glucose Deprivation and Lactic Acidosis Induce Mitotic Chromosomal Instability \u2013 An Implication in Aneuploid Human Tumors. Chi J-TA, editor. PLoS ONE. 2013;8:e63054.","DOI":"10.1371\/journal.pone.0063054"},{"key":"682_CR81","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1186\/s12885-020-07015-9","volume":"20","author":"B Hoffmann","year":"2020","unstructured":"Hoffmann B, Lange T, Labitzky V, Riecken K, Wree A, Schumacher U, et al. The initial engraftment of tumor cells is critical for the future growth pattern: a mathematical study based on simulations and animal experiments. BMC Cancer. 2020;20:524.","journal-title":"BMC Cancer"},{"key":"682_CR82","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.canlet.2020.06.004","volume":"489","author":"VM Todd","year":"2020","unstructured":"Todd VM, Johnson RW. Hypoxia in bone metastasis and osteolysis. Cancer Lett. 2020;489:144\u201354.","journal-title":"Cancer Lett"},{"key":"682_CR83","doi-asserted-by":"publisher","first-page":"789","DOI":"10.4161\/cbt.28552","volume":"15","author":"M Jiang","year":"2014","unstructured":"Jiang M, Xu X, Bi Y, Xu J, Qin C, Han M. Systemic inflammation promotes lung metastasis via E-selectin upregulation in mouse breast cancer model. Cancer Biol Ther. 2014;15:789\u201396.","journal-title":"Cancer Biol Ther"},{"key":"682_CR84","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.3390\/ijms22115703","volume":"22","author":"V Infantino","year":"2021","unstructured":"Infantino V, Santarsiero A, Convertini P, Todisco S, Iacobazzi V. Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target. Int J Mol Sci. 2021;22:5703.","journal-title":"Int J Mol Sci"},{"key":"682_CR85","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0171-2985(82)80083-1","volume":"161","author":"JL Turk","year":"1982","unstructured":"Turk JL, Narayanan RB. The origin, morphology, and function of epithelioid cells. Immunobiology. 1982;161:274\u201382.","journal-title":"Immunobiology"},{"key":"682_CR86","doi-asserted-by":"crossref","unstructured":"Mello ES, Alves VAF. Hepatic Granulomas. Pract Hepatic Pathol Diagn Approach. Elsevier; 2011 [cited 2025 Mar 27]. pp. 291\u2013302. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780443068034000228","DOI":"10.1016\/B978-0-443-06803-4.00022-8"},{"key":"682_CR87","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1128\/JVI.01924-06","volume":"81","author":"M Filippova","year":"2007","unstructured":"Filippova M, Johnson MM, Bautista M, Filippov V, Fodor N, Tungteakkhun SS, et al. The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect Procaspase 8 stability and activity. J Virol. 2007;81:4116\u201329.","journal-title":"J Virol"},{"key":"682_CR88","doi-asserted-by":"publisher","first-page":"13232","DOI":"10.1128\/JVI.77.24.13232-13247.2003","volume":"77","author":"M Tao","year":"2003","unstructured":"Tao M, Kruhlak M, Xia S, Androphy E, Zheng Z-M. SignalsThat dictate nuclear localization of human papillomavirus type 16Oncoprotein E6 in livingcells. J Virol. 2003;77:13232\u201347.","journal-title":"J Virol"},{"key":"682_CR89","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.4049\/jimmunol.167.9.5420","volume":"167","author":"M Evans","year":"2001","unstructured":"Evans M, Borysiewicz LK, Evans AS, Rowe M, Jones M, Gileadi U, et al. Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6. J Immunol. 2001;167:5420\u20138.","journal-title":"J Immunol"},{"key":"682_CR90","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s00262-022-03350-x","volume":"72","author":"SJ Santegoets","year":"2023","unstructured":"Santegoets SJ, Welters MJP, Schrikkema DS, Freriks MR, Kok H, Weissbrich B, et al. The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer. Cancer Immunol Immunother. 2023;72:1553\u201365.","journal-title":"Cancer Immunol Immunother"},{"key":"682_CR91","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/jnci\/89.17.1285","volume":"89","author":"AS Kadish","year":"1997","unstructured":"Kadish AS, Ho GY, Burk RD, Wang Y, Romney SL, Ledwidge R, et al. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia. JNCI J Natl Cancer Inst. 1997;89:1285\u201393.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"682_CR92","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2249.2009.04006.x","volume":"159","author":"I Bourgault Villada","year":"2009","unstructured":"Bourgault Villada I, Moyal Barracco M, Berville S, Bafounta ML, Longvert C, Pr\u00e9mel V, et al. Human papillomavirus 16-specific T cell responses in classic HPV-related vulvar intra-epithelial neoplasia. Determination of strongly Immunogenic regions from E6 and E7 proteins. Clin Exp Immunol. 2009;159:45\u201356.","journal-title":"Clin Exp Immunol"},{"key":"682_CR93","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10989-020-10089-5","volume":"27","author":"B Bahmani","year":"2021","unstructured":"Bahmani B, Amini-bayat Z, Ranjbar MM, Bakhtiari N, Zarnani A-H. HPV16-E7 protein T cell epitope prediction and global therapeutic peptide vaccine design based on human leukocyte antigen frequency: an In-Silico study. Int J Pept Res Ther. 2021;27:365\u201378.","journal-title":"Int J Pept Res Ther"},{"key":"682_CR94","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1128\/CDLI.12.8.1003-1005.2005","volume":"12","author":"M Nakagawa","year":"2005","unstructured":"Nakagawa M, Kim KH, Moscicki A-B. Patterns of CD8 T-Cell epitopes within the human papillomavirus type 16 (HPV 16) E6 protein among young women whose HPV 16 infection has become undetectable. Clin Vaccine Immunol. 2005;12:1003\u20135.","journal-title":"Clin Vaccine Immunol"},{"key":"682_CR95","doi-asserted-by":"publisher","first-page":"14904","DOI":"10.1038\/s41598-018-33298-x","volume":"8","author":"EEG Kozlova","year":"2018","unstructured":"Kozlova EEG, Cerf L, Schneider FS, Viart BT, NGuyen C, Steiner BT, et al. Computational B-cell epitope identification and production of neutralizing murine antibodies against Atroxlysin-I. Sci Rep. 2018;8:14904.","journal-title":"Sci Rep"},{"key":"682_CR96","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12985-021-01728-4","volume":"19","author":"J He","year":"2022","unstructured":"He J, Li Q, Ma S, Li T, Chen Y, Liu Y, et al. The polymorphism analysis and epitope predicted of alphapapillomavirus 9 E6 in sichuan, China. Virol J. 2022;19:14.","journal-title":"Virol J"},{"key":"682_CR97","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S0198-8859(03)00033-8","volume":"64","author":"I Zehbe","year":"2003","unstructured":"Zehbe I, Mytilineos J, Wikstr\u00f6m I, Henriksen R, Edler L, Tommasino M. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. Hum Immunol. 2003;64:538\u201342.","journal-title":"Hum Immunol"},{"key":"682_CR98","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1006\/viro.2001.0905","volume":"284","author":"A Kjerrstr\u00f6m","year":"2001","unstructured":"Kjerrstr\u00f6m A, Hinkula J, Engstr\u00f6m G, Ovod V, Krohn K, Benthin R, et al. Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines. Virology. 2001;284:46\u201361.","journal-title":"Virology"},{"key":"682_CR99","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.1016\/j.vaccine.2005.08.018","volume":"24","author":"A Br\u00e5ve","year":"2006","unstructured":"Br\u00e5ve A, Ljungberg K, Boberg A, Rollman E, Engstr\u00f6m G, Hinkula J, et al. Reduced cellular immune responses following immunization with a multi-gene HIV-1 vaccine. Vaccine. 2006;24:4524\u20136.","journal-title":"Vaccine"},{"key":"682_CR100","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","volume":"8","author":"RA Seder","year":"2008","unstructured":"Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol. 2008;8:247\u201358.","journal-title":"Nat Rev Immunol"},{"key":"682_CR101","doi-asserted-by":"crossref","unstructured":"Rosa DS, Ribeiro SP, Almeida RR, Mairena EC, Post\u00f3l E, Kalil J et al. A DNA Vaccine Encoding Multiple HIV CD4 Epitopes Elicits Vigorous Polyfunctional, Long-Lived CD4\u2009+\u2009and CD8\u2009+\u2009T Cell Responses. Ndhlovu L, editor. PLoS ONE. 2011;6:e16921.","DOI":"10.1371\/journal.pone.0016921"},{"key":"682_CR102","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1158\/2326-6066.CIR-15-0009","volume":"3","author":"TA Waldmann","year":"2015","unstructured":"Waldmann TA. The shared and contrasting roles of interleukin-2 (IL-2) and IL-15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy. Cancer Immunol Res. 2015;3:219\u201327.","journal-title":"Cancer Immunol Res"},{"key":"682_CR103","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2010-08-265892","volume":"118","author":"P Lacy","year":"2011","unstructured":"Lacy P, Stow JL. Cytokine release from innate immune cells: association with diverse membrane trafficking pathways. Blood. 2011;118:9\u201318.","journal-title":"Blood"},{"key":"682_CR104","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","volume":"8","author":"D Jorgovanovic","year":"2020","unstructured":"Jorgovanovic D, Song M, Wang L, Zhang Y. Roles of IFN-\u03b3 in tumor progression and regression: a review. Biomark Res. 2020;8:49.","journal-title":"Biomark Res"},{"key":"682_CR105","doi-asserted-by":"crossref","unstructured":"Falvo JV, Tsytsykova AV, Goldfeld AE. Transcriptional Control of the TNF Gene. In: Kollias G, Sfikakis PP, editors. Curr Dir Autoimmun. Basel: KARGER; 2010 [cited 2025 Mar 27]. pp. 27\u201360. Available from: https:\/\/karger.com\/books\/book\/2686\/chapter\/5760700","DOI":"10.1159\/000289196"},{"key":"682_CR106","unstructured":"Tumor Necrosis Factor Alpha. - an overview| ScienceDirect Topics. [cited 2025 Mar 27]. Available from: https:\/\/www.sciencedirect.com\/topics\/biochemistry-genetics-and-molecular-biology\/tumor-necrosis-factor-alpha"},{"key":"682_CR107","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1089\/10430349950016474","volume":"10","author":"H Ji","year":"1999","unstructured":"Ji H, Wang T-L, Chen C-H, Pai SI, Hung C-F, Lin K-Y, et al. Targeting human papillomavirus type 16 E7 to the endosomal\/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-Expressing tumors. Hum Gene Ther. 1999;10:2727\u201340.","journal-title":"Hum Gene Ther"},{"key":"682_CR108","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/PL00012108","volume":"6","author":"N Saito","year":"2001","unstructured":"Saito N, Mitsuhashi M, Hayashi T, Narumo C, Nagata H, Soyama K, et al. Inhibition of hepatic metastasis in mice treated with cell-binding domain of human fibronectin and angiogenesis inhibitor TNP-470. Int J Clin Oncol. 2001;6:215\u201320.","journal-title":"Int J Clin Oncol"},{"key":"682_CR109","doi-asserted-by":"crossref","unstructured":"Egan CE, Daugherity EK, Rogers AB, Abi Abdallah DS, Denkers EY, Maurer KJ. CCR2 and CD44 Promote Inflammatory Cell Recruitment during Fatty Liver Formation in a Lithogenic Diet Fed Mouse Model. Moser M, editor. PLoS ONE. 2013;8:e65247.","DOI":"10.1371\/journal.pone.0065247"},{"key":"682_CR110","doi-asserted-by":"publisher","first-page":"153535002004031","DOI":"10.1162\/15353500200403196","volume":"3","author":"T Troy","year":"2004","unstructured":"Troy T, Jekic-McMullen D, Sambucetti L, Rice B. Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol Imaging. 2004;3:15353500200403196.","journal-title":"Mol Imaging"},{"key":"682_CR111","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.2832","volume":"26","author":"I Campbell","year":"2007","unstructured":"Campbell I. Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations. Stat Med. 2007;26:3661\u201375.","journal-title":"Stat Med"},{"key":"682_CR112","doi-asserted-by":"publisher","unstructured":"The analysis of. 2 \u00d7 2 contingency tables\u2014Yet again - Richardson\u2013\u20092011 - Statistics in Medicine - Wiley Online Library. [cited 2025 Mar 27]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/sim.4116","DOI":"10.1002\/sim.4116"},{"key":"682_CR113","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.1016\/j.vaccine.2007.08.036","volume":"25","author":"B Huang","year":"2007","unstructured":"Huang B, Mao C-P, Peng S, He L, Hung C-F, Wu T-C. Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency. Vaccine. 2007;25:7824\u201331.","journal-title":"Vaccine"},{"key":"682_CR114","doi-asserted-by":"publisher","unstructured":"Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 Breast Tumor Model. Curr Protoc Immunol. 2000 [cited 2025 Mar 27];39. Available from: https:\/\/currentprotocols.onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/0471142735.im2002s39","DOI":"10.1002\/0471142735.im2002s39"},{"key":"682_CR115","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.virusres.2016.11.023","volume":"231","author":"JA Westrich","year":"2017","unstructured":"Westrich JA, Warren CJ, Pyeon D. Evasion of host immune defenses by human papillomavirus. Virus Res. 2017;231:21\u201333.","journal-title":"Virus Res"},{"key":"682_CR116","doi-asserted-by":"publisher","first-page":"e29685","DOI":"10.1002\/jmv.29685","volume":"96","author":"I Lo Cigno","year":"2024","unstructured":"Lo Cigno I, Calati F, Girone C, Catozzo M, Gariglio M. High-risk HPV oncoproteins E6 and E7 and their interplay with the innate immune response: Uncovering mechanisms of immune evasion and therapeutic prospects. J Med Virol. 2024;96:e29685.","journal-title":"J Med Virol"},{"key":"682_CR117","doi-asserted-by":"crossref","unstructured":"James CD, Fontan CT, Otoa R, Das D, Prabhakar AT, Wang X et al. Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription. Imperiale MJ, editor. mSphere. 2020;5:e00828-19.","DOI":"10.1128\/mSphere.00828-19"},{"key":"682_CR118","doi-asserted-by":"publisher","first-page":"34789","DOI":"10.1038\/srep34789","volume":"6","author":"K Jemon","year":"2016","unstructured":"Jemon K, Leong C-M, Ly K, Young SL, McLellan AD, Hibma MH. Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted mice. Sci Rep. 2016;6:34789.","journal-title":"Sci Rep"},{"key":"682_CR119","doi-asserted-by":"publisher","first-page":"103675","DOI":"10.1016\/j.critrevonc.2022.103675","volume":"174","author":"R Bhattacharjee","year":"2022","unstructured":"Bhattacharjee R, Das SS, Biswal SS, Nath A, Das D, Basu A, et al. Mechanistic role of HPV-associated early proteins in cervical cancer: molecular pathways and targeted therapeutic strategies. Crit Rev Oncol Hematol. 2022;174:103675.","journal-title":"Crit Rev Oncol Hematol"},{"key":"682_CR120","first-page":"384","volume":"55","author":"SD Balasubramaniam","year":"2019","unstructured":"Balasubramaniam SD, Balakrishnan V, Oon CE, Kaur G. Key molecular events in cervical Cancer development. Med (Mex). 2019;55:384.","journal-title":"Med (Mex)"},{"key":"682_CR121","doi-asserted-by":"crossref","unstructured":"Ajiro M, Jia R, Zhang L, Liu X, Zheng Z-M. Intron Definition and a Branch Site Adenosine at nt 385 Control RNA Splicing of HPV16 E6*I and E7 Expression. Qiu J, editor. PLoS ONE. 2012;7:e46412.","DOI":"10.1371\/journal.pone.0046412"},{"key":"682_CR122","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1002\/ijc.23415","volume":"122","author":"N Ma","year":"2008","unstructured":"Ma N, Kawanishi M, Hiraku Y, Murata M, Huang G-W, Huang Y, et al. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression. Int J Cancer. 2008;122:2517\u201325.","journal-title":"Int J Cancer"},{"key":"682_CR123","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1182\/blood-2011-04-347112","volume":"118","author":"GM Taylor","year":"2011","unstructured":"Taylor GM, Raghuwanshi SK, Rowe DT, Wadowsky RM, Rosendorff A. Endoplasmic reticulum stress causes EBV lytic replication. Blood. 2011;118:5528\u201339.","journal-title":"Blood"},{"key":"682_CR124","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1038\/onc.2010.36","volume":"29","author":"W-L Tsai","year":"2010","unstructured":"Tsai W-L, Chung RT. Viral hepatocarcinogenesis. Oncogene. 2010;29:2309\u201324.","journal-title":"Oncogene"},{"key":"682_CR125","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jmb.2004.02.023","volume":"337","author":"Z-M Zheng","year":"2004","unstructured":"Zheng Z-M, Tao M, Yamanegi K, Bodaghi S, Xiao W. Splicing of a cap-proximal human papillomavirus 16 E6E7 intron promotes E7 expression, but can be restrained by distance of the intron from its RNA 5\u2032 cap. J Mol Biol. 2004;337:1091\u2013108.","journal-title":"J Mol Biol"},{"key":"682_CR126","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1128\/JVI.80.9.4249-4263.2006","volume":"80","author":"S Tang","year":"2006","unstructured":"Tang S, Tao M, McCoy JP, Zheng Z-M. The E7 oncoprotein is translated from spliced E6*I transcripts in High-Risk human papillomavirus type 16- or type 18-Positive cervical Cancer cell lines via translation reinitiation. J Virol. 2006;80:4249\u201363.","journal-title":"J Virol"},{"key":"682_CR127","doi-asserted-by":"crossref","unstructured":"Williams VM, Filippova M, Filippov V, Payne KJ, Duerksen-Hughes P. Human Papillomavirus Type 16 E6* Induces Oxidative Stress and DNA Damage. Imperiale MJ, editor. J Virol. 2014;88:6751\u201361.","DOI":"10.1128\/JVI.03355-13"},{"key":"682_CR128","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/v10010045","volume":"10","author":"L Olmedo-Nieva","year":"2018","unstructured":"Olmedo-Nieva L, Mu\u00f1oz-Bello J, Contreras-Paredes A, Lizano M. The role of E6 spliced isoforms (E6*) in human Papillomavirus-Induced carcinogenesis. Viruses. 2018;10:45.","journal-title":"Viruses"},{"key":"682_CR129","doi-asserted-by":"publisher","first-page":"7403","DOI":"10.1038\/sj.onc.1203134","volume":"18","author":"D Pim","year":"1999","unstructured":"Pim D, Banks L. HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6. Oncogene. 1999;18:7403\u20138.","journal-title":"Oncogene"},{"key":"682_CR130","doi-asserted-by":"publisher","first-page":"9863","DOI":"10.1128\/JVI.00539-09","volume":"83","author":"D Pim","year":"2009","unstructured":"Pim D, Tomai\u0107 V, Banks L. The human papillomavirus (HPV) E6* proteins from High-Risk, mucosal HPVs can direct degradation of cellular proteins in the absence of Full-Length E6 protein. J Virol. 2009;83:9863\u201374.","journal-title":"J Virol"},{"key":"682_CR131","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1099\/vir.0.038265-0","volume":"93","author":"P Wanichwatanadecha","year":"2012","unstructured":"Wanichwatanadecha P, Sirisrimangkorn S, Kaewprag J, Ponglikitmongkol M. Transactivation activity of human papillomavirus type 16 E6*I on aldo-keto reductase genes enhances chemoresistance in cervical cancer cells. J Gen Virol. 2012;93:1081\u201392.","journal-title":"J Gen Virol"},{"key":"682_CR132","doi-asserted-by":"publisher","first-page":"200311","DOI":"10.1016\/j.tvr.2024.200311","volume":"19","author":"W Kathleen","year":"2024","unstructured":"Kathleen W. Too many cooks in the kitchen: HPV driven carcinogenesis \u2013 The result of collaboration or competition? Tumour Virus Res. 2024;19:200311.","journal-title":"Tumour Virus Res"},{"key":"682_CR133","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3892\/ol.2014.2698","volume":"9","author":"K Lin","year":"2015","unstructured":"Lin K, Lu X, Chen J, Zou R, Zhang L, Xue X. E6-associated transcription patterns in human papilloma virus 16-positive cervical tissues. Oncol Lett. 2015;9:478\u201382.","journal-title":"Oncol Lett"},{"key":"682_CR134","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s00705-010-0787-9","volume":"155","author":"O Del Moral-Hern\u00e1ndez","year":"2010","unstructured":"Del Moral-Hern\u00e1ndez O, L\u00f3pez-Urrutia E, Bonilla-Moreno R, Mart\u00ednez-Salazar M, Arechaga-Ocampo E, Berumen J, et al. The HPV-16 E7 oncoprotein is expressed mainly from the unspliced E6\/E7 transcript in cervical carcinoma C33-A cells. Arch Virol. 2010;155:1959\u201370.","journal-title":"Arch Virol"},{"key":"682_CR135","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/hep.30945","volume":"71","author":"W Zhong","year":"2020","unstructured":"Zhong W, Wei X, Hao L, Lin T-D, Yue R, Sun X, et al. Paneth cell dysfunction mediates Alcohol-related steatohepatitis through promoting bacterial translocation in mice: role of zinc deficiency. Hepatol Baltim Md. 2020;71:1575\u201391.","journal-title":"Hepatol Baltim Md"},{"key":"682_CR136","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1128\/JVI.03434-14","volume":"89","author":"M McFarlane","year":"2015","unstructured":"McFarlane M, MacDonald AI, Stevenson A, Graham SV. Human papillomavirus 16 oncoprotein expression is controlled by the cellular splicing factor SRSF2 (SC35). Imperiale MJ, editor. J Virol. 2015;89:5276\u201387.","journal-title":"J Virol"},{"key":"682_CR137","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1016\/j.celrep.2019.10.110","volume":"29","author":"S Park","year":"2019","unstructured":"Park S, Brugiolo M, Akerman M, Das S, Urbanski L, Geier A, et al. Differential functions of splicing factors in mammary transformation and breast Cancer metastasis. Cell Rep. 2019;29:2672\u2013e26887.","journal-title":"Cell Rep"},{"key":"682_CR138","doi-asserted-by":"publisher","first-page":"R467","DOI":"10.1530\/ERC-18-0068","volume":"25","author":"A Read","year":"2018","unstructured":"Read A, Natrajan R. Splicing dysregulation as a driver of breast cancer. Endocr Relat Cancer. 2018;25:R467\u201378.","journal-title":"Endocr Relat Cancer"},{"key":"682_CR139","doi-asserted-by":"publisher","first-page":"e1476","DOI":"10.1002\/wrna.1476","volume":"9","author":"LM Urbanski","year":"2018","unstructured":"Urbanski LM, Leclair N, Anczuk\u00f3w O. Alternative-splicing defects in cancer: splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics. Wiley Interdiscip Rev RNA. 2018;9:e1476.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"682_CR140","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.3816\/CBC.2009.s.008","volume":"9","author":"CK Anders","year":"2009","unstructured":"Anders CK, Carey LA, Biology. Metastatic patterns, and treatment of patients with Triple-Negative breast Cancer. Clin Breast Cancer. 2009;9:S73\u201381.","journal-title":"Clin Breast Cancer"},{"key":"682_CR141","first-page":"1615","volume":"13","author":"S Zhou","year":"2020","unstructured":"Zhou S, Peng F. Patterns of metastases in cervical cancer: a population-based study. Int J Clin Exp Pathol. 2020;13:1615\u201323.","journal-title":"Int J Clin Exp Pathol"},{"key":"682_CR142","doi-asserted-by":"publisher","first-page":"5880","DOI":"10.7150\/jca.46258","volume":"11","author":"X Chen","year":"2020","unstructured":"Chen X, Chen L, Zhu H, Tao J. Risk factors and prognostic predictors for cervical Cancer patients with lung metastasis. J Cancer. 2020;11:5880\u20139.","journal-title":"J Cancer"},{"key":"682_CR143","doi-asserted-by":"publisher","first-page":"8203","DOI":"10.1016\/j.vaccine.2010.08.108","volume":"28","author":"A Br\u00e5ve","year":"2010","unstructured":"Br\u00e5ve A, Gudmundsdotter L, Sandstr\u00f6m E, Haller BK, Halleng\u00e4rd D, Maltais A-K, et al. Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation. Vaccine. 2010;28:8203\u20139.","journal-title":"Vaccine"},{"key":"682_CR144","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1016\/j.vaccine.2009.04.013","volume":"27","author":"A Br\u00e5ve","year":"2009","unstructured":"Br\u00e5ve A, Halleng\u00e4rd D, Gudmundsdotter L, Stout R, Walters R, Wahren B, et al. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen. Vaccine. 2009;27:3692\u20136.","journal-title":"Vaccine"},{"key":"682_CR145","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1158\/1078-0432.CCR-07-1881","volume":"14","author":"GG Kenter","year":"2008","unstructured":"Kenter GG, Welters MJP, Valentijn ARPM, L\u00f6wik MJG, Berends-van Der Meer DMA, Vloon APG, et al. Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of High-Risk human papillomavirus 16 in End-Stage cervical Cancer patients shows low toxicity and robust immunogenicity. Clin Cancer Res. 2008;14:169\u201377.","journal-title":"Clin Cancer Res"},{"key":"682_CR146","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1016\/j.vaccine.2017.05.081","volume":"35","author":"Y Ma","year":"2017","unstructured":"Ma Y, Yang A, Peng S, Qiu J, Farmer E, Hung C-F, et al. Characterization of HPV18 E6-specific T cell responses and establishment of HPV18 E6-expressing tumor model. Vaccine. 2017;35:3850\u20138.","journal-title":"Vaccine"},{"key":"682_CR147","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/sj.cgt.7700723","volume":"11","author":"AP Wlazlo","year":"2004","unstructured":"Wlazlo AP, Deng H, Giles-Davis W, Ertl HCJ. DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins. Cancer Gene Ther. 2004;11:457\u201364.","journal-title":"Cancer Gene Ther"},{"key":"682_CR148","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12967-015-0437-9","volume":"13","author":"M Bissa","year":"2015","unstructured":"Bissa M, Illiano E, Pacchioni S, Paolini F, Zanotto C, De Giuli Morghen C, et al. A prime\/boost strategy using dna\/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers. J Transl Med. 2015;13:80.","journal-title":"J Transl Med"},{"key":"682_CR149","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s11373-006-9086-6","volume":"13","author":"C-T Lin","year":"2006","unstructured":"Lin C-T, Tsai Y-C, He L, Calizo R, Chou H-H, Chang T-C, et al. A DNA vaccine encoding a Codon-Optimized human papillomavirus type 16 E6 gene enhances CTL response and Anti-tumor activity. J Biomed Sci. 2006;13:481\u20138.","journal-title":"J Biomed Sci"},{"key":"682_CR150","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s11373-005-9012-3","volume":"12","author":"S Peng","year":"2005","unstructured":"Peng S, Trimble C, Ji H, He L, Tsai Y-C, Macaes B, et al. Characterization of HPV-16 E6 DNA vaccines employing intracellular targeting and intercellular spreading strategies. J Biomed Sci. 2005;12:689\u2013700.","journal-title":"J Biomed Sci"},{"key":"682_CR151","doi-asserted-by":"publisher","first-page":"8468","DOI":"10.1128\/JVI.78.16.8468-8476.2004","volume":"78","author":"S Peng","year":"2004","unstructured":"Peng S, Ji H, Trimble C, He L, Tsai Y-C, Yeatermeyer J, et al. Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6. J Virol. 2004;78:8468\u201376.","journal-title":"J Virol"},{"key":"682_CR152","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0168-1702(00)00241-0","volume":"73","author":"R Azoury-Ziadeh","year":"2001","unstructured":"Azoury-Ziadeh R, Herd K, Fernando GJP, Lambert P, Frazer IH, Tindle RW. Low level expression of human papillomavirus type 16 (HPV16) E6 in squamous epithelium does not elicit E6 specific B- or T-helper immunological responses, or influence the outcome of immunisation with E6 protein. Virus Res. 2001;73:189\u201399.","journal-title":"Virus Res"},{"key":"682_CR153","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/jgm.733","volume":"7","author":"D Pokorn\u00e1","year":"2005","unstructured":"Pokorn\u00e1 D, Mackov\u00e1 J, Du\u0161kov\u00e1 M, Rittich \u0160, Ludv\u00edkov\u00e1 V, \u0160mahel M. Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect. J Gene Med. 2005;7:696\u2013707.","journal-title":"J Gene Med"},{"key":"682_CR154","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/S0264-410X(02)00519-4","volume":"21","author":"M \u0160mahel","year":"2003","unstructured":"\u0160mahel M, \u0160\u0131\u0301ma P, Ludv\u0131\u0301kov\u00e1 V, Marinov I, Pokorn\u00e1 D, Vonka V. Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules. Vaccine. 2003;21:1125\u201336.","journal-title":"Vaccine"},{"key":"682_CR155","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.vaccine.2008.10.078","volume":"27","author":"J Yan","year":"2009","unstructured":"Yan J, Reichenbach DK, Corbitt N, Hokey DA, Ramanathan MP, McKinney KA, et al. Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6\/E7 fusion antigen. Vaccine. 2009;27:431\u201340.","journal-title":"Vaccine"},{"key":"682_CR156","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/cancers11010096","volume":"11","author":"R Garza-Morales","year":"2019","unstructured":"Garza-Morales R, Perez-Trujillo JJ, Martinez-Jaramillo E, Saucedo-Cardenas O, Loera-Arias MJ, Garcia-Garcia A, et al. A DNA vaccine encoding SA-4-1BBL fused to HPV-16 E7 antigen has prophylactic and therapeutic efficacy in a cervical Cancer mouse model. Cancers. 2019;11:96.","journal-title":"Cancers"},{"key":"682_CR157","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/intimm\/11.9.1491","volume":"11","author":"K Kimura","year":"1999","unstructured":"Kimura K, Ando K, Ohnishi H, Ishikawa T, Kakumu S, Takemura M, et al. Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered Concanavalin A. Int Immunol. 1999;11:1491\u2013500.","journal-title":"Int Immunol"},{"key":"682_CR158","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00441-002-0670-4","volume":"311","author":"S Kobayashi","year":"2003","unstructured":"Kobayashi S, Seki S, Kawada N, Morikawa H, Nakatani K, Uyama N, et al. Apoptosis of T cells in the hepatic fibrotic tissue of the rat: a possible inducing role of hepatic myofibroblast-like cells. Cell Tissue Res. 2003;311:353\u201364.","journal-title":"Cell Tissue Res"},{"key":"682_CR159","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/0023677215572841","volume":"49","author":"F Heymann","year":"2015","unstructured":"Heymann F, Hamesch K, Weiskirchen R, Tacke F. The Concanavalin A model of acute hepatitis in mice. Lab Anim. 2015;49:12\u201320.","journal-title":"Lab Anim"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00682-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-025-00682-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00682-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:09:34Z","timestamp":1757308174000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-025-00682-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":159,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1186\/s13027-025-00682-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6328033\/v1","asserted-by":"object"}]},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A retrospective study of HR HPVs in the cervical tissues of women with high grade cervical lesions and cervical carcinomas diagnosed at the Paul Stradins University hospital was performed according to the ethical permit issued by the Ethical Committee of the Riga Stradins University N2-P\u0112K-4\/415\/2022 dated September 26, 2022. Informed consents to use biological materials in biomedical research were given by patients at the time of sampling. Experiments in the laboratory mice were carried out in compliance with the bioethical principles adopted by the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes (Strasbourg, 1986). Experimental procedures were approved by the Ethical Committee of the Latvian Food and Veterinary service (protocol nr 1.1\u201313\/18\/953), permit No 99 dated June 1, 2018, valid 01.06.2018\u201325.05.2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Manuscript does not contain any individual person\u2019s data in any form, such as individual details, images or videos, and does not require consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Co-authors of this manuscript Dmitry Perminov and Ilze Lindenberga are employees of the E. Gulbja Laboratorija, Riga, Latvia, and performed analysis of the anonymized\/blinded DNA samples according to the subcontract of Riga Stradins University, Riga, Latvia, financed by the project of the Latvian Science Fund 2021\/1-0484. Maria Isaguliants is a member of the Editorial Board of \u201cInfectious Agents and Cancer\u201d. Other authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}